News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biothera Data Strengthens Imprime PGG Biomarker Correlation



3/10/2014 8:11:09 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EAGAN, Minn.--(BUSINESS WIRE)--Biothera will present data today demonstrating a threshold presence of anti-beta glucan antibodies (ABA), IgG and IgM are predictive of binding of the company’s cancer immunotherapy Imprime PGG® to neutrophils and monocytes, which can then recognize and kill cancer cells. The presentation is part of the Keystone Symposia on Inflammation, Infection and Cancer in Whistler, British Columbia, Canada.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Biothera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES